Suki Subbiah
Impact in
-
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 6
- Chronic Lymphocytic Leukemia Research 6
-
- Lymphoma Diagnosis and Treatment 5
- Co-authors
- Hun Ju Lee (6 shared papers)William G. Wierda (6 shared papers)James B. Breitmeyer (6 shared papers)Iris Isufi (6 shared papers)Catriona Jamieson (6 shared papers)Alec Goldenberg (6 shared papers)Michael Y. Choi (6 shared papers)Thomas J. Kipps (6 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Blood (3 papers)Open Forum Infectious Diseases (1 paper)JNCI Journal of the National Cancer Institute (1 paper)DOAJ (DOAJ: Directory of Open Access Journals) (1 paper)
- Partner nations
- United StatesMexico
In The Last Decade
Suki Subbiah
11 papers receiving 56 citations
Peers
Comparison fields: 5 of 20
- Genetics 22
- Pathology and Forensic Medicine 20
- Oncology 30
- Internal Medicine 3
- Toxicology 2
Countries citing papers authored by Suki Subbiah
This map shows the geographic impact of Suki Subbiah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suki Subbiah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suki Subbiah more than expected).
Fields of papers citing papers by Suki Subbiah
This network shows the impact of papers produced by Suki Subbiah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suki Subbiah. The network helps show where Suki Subbiah may publish in the future.
Co-authors
The 25 scholars most cited alongside Suki Subbiah, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 21 | |
| 2 | 2022 | 10 | |
| 3 | 2022 | 6 | |
| 4 | 2020 | 5 | |
| 5 | 2021 | 4 | |
| 6 | 2020 | 4 | |
| 7 | 2021 | 2 | |
| 8 | 2011 | 2 | |
| 9 | 2021 | 1 | |
| 10 | 2022 | 1 | |
| 11 | 2011 | 1 | |
| 12 | 2024 | 0 | |
| 13 | 2023 | 0 | |
| 14 | 2022 | 0 |
About Suki Subbiah
Suki Subbiah is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 57 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Galectins and Cancer Biology (3 papers), COVID-19 and healthcare impacts (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Gastric Cancer Management and Outcomes (2 papers) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Genetics (22 citations), Pathology and Forensic Medicine (20 citations), Oncology (30 citations), Internal Medicine (3 citations) and Toxicology (2 citations). Suki Subbiah has collaborated with scholars based in United States and Mexico. Frequent co-authors include Hun Ju Lee, William G. Wierda, James B. Breitmeyer, Iris Isufi, Catriona Jamieson, Alec Goldenberg, Michael Y. Choi, Thomas J. Kipps, Tanya Siddiqi and Nicole Lamanna. Their work appears in journals such as Journal of Clinical Oncology, Blood, Open Forum Infectious Diseases, JNCI Journal of the National Cancer Institute and DOAJ (DOAJ: Directory of Open Access Journals).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.